Evidence for a possible synergism between pituitary adenylate cyclase activating polypeptide and calcitonin gene-related peptide in porcine ophthalmic artery

Acta Ophthalmologica Scandinavica

Volumn 75, Issue 2, 1997, Pages 159-161

  Elsås, Tor ^a   White, Linda R ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

CGRP; Neuropeptides; Ophthalmic artery; PACAP

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; NEUROPEPTIDE;

ANIMAL TISSUE; ARTICLE; NONHUMAN; OPHTHALMIC ARTERY; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; SWINE;

EID: 0030965336     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.1997.tb00114.x     Document Type: Article

References (20)

1. Bakken IJ, Vincent MB, Sjaavaag I & White LR (1995): Vasodilation in porcine ophthalmic artery: peptide interaction with acetylcholine and endothelial dependence. Neuropeptides 29: 69-75.
2. Bill A (1991): Effect of some neuropeptides on the uvea. Exp Eye Res 53: 3-11.
3. Cardell LO, Uddman R, Luts A & Sundler F (1991): Pituitary adenylate cyclase activating peptide (PACAP) in guinea-pig lung: distribution and dilatory effects. Regul Pept 36: 379-390.
4. Edvinsson L, Ekblad E, Håkanson R & Wahlestedt C (1984): Neuropeptide Y potentiates the effect of various vasoconstrictors on rabbit blood vessels. Br J Pharmacol 83: 519-525.
5. Edvinsson L, Fredholm BB, Hamel E, Jansen I & Verrechia C (1985): Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic monophosphate accumulation or release of endothelium-derived relaxing factor in the cat. Neurosci Lett 58: 213-217.
6. Edvinsson L & Goadsby PJ (1990): Extracerebral manifestations of migraine. A peptidergic involvement? J Intern Med 228: 299-304.
7. Edvinsson L & Adamsson M (1992): Neuropeptide Y inhibits relaxation of guinea pig cerebral, coronary, and uterine arteries: blockade by D-myo-inositol-1,2,6-triphosphate. J Cardiovasc Pharmacol 20: 466-472.
8. Högestätt ED, Andersson KE & Edvinsson L (1983): Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol Scand 117: 49-61.
9. Mikkelsen JD, Hannibal J, Larsen JL & Fahrenkrug J (1994): Pituitary adenylate cyclase activating peptide (PACAP) mRNA in the rat neocortex. Neurosci Lett 171: 121-124.
10. Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L, Culler MD & Coy DH (1989): Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164: 567-574.
11. Miyata A, Jiang L, Dahl RD, Kitada C, Kubo K, Fujino M, Minamino N & Arimura A (1990): Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun 170: 643-648.
12. Moller K, Zhang YZ, Håkanson R, Luts A, Sjölund B, Uddman R & Sundler F (1993): Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: immunocytochemical and immunochemical evidence. Neuroscience 57: 725-732.
13. Mulder H, Uddman R, Moller K, Zhang YZ, Ekblad E, Alumets J & Sundler F (1994): Pituitary adenylate cyclase activating polypeptide expression in sensory neurons. Neuroscience 63: 307-312.
14. Nandha KA, Benito-Orfila MA, Smith DM, Ghatei MA & Bloom SR (1991): Action of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on the rat vascular system: effects on blood pressure and receptor binding. J Endocrinol 129: 69-73.
15. Nilsson SFE (1994): PACAP-27 and PACAP-38: vascular effects in the eye and some other tissues in the rabbit. Eur J Pharmacol 253: 17-25.
16. Sundler F, Ekblad E, Absood A, Håkanson R, Köves R & Arimura A (1991): Pituitary adenylate cyclase activating peptide: a novel vasoactive intestinal peptide-like neuropeptide in the gut. Neuroscience 46: 439-454.
17. Vincent MB, White LR, Elsås T, Qvigstad G & Sjaastad O (1992): Substance P augments the rate of vasodilation induced by calcitonin gene-related peptide in porcine ophthalmic artery in vitro. Neuropeptides 22: 137-141.
18. Warren JB, Donnelly LE, Cullen S, Robertson BE, Ghatei MA, Bloom SR & MacDermot J (1991): Pituitary adenylate cyclase activating polypeptide: a novel, long-lasting, endothelium-independent vasorelaxant. Eur J Pharmacol 197: 131-134.
19. Warren JB, Cockcroft JR, Larkin SW, Kajekar R, Macrae A, Ghatei MA & Bloom SR (1992): Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humans. J Cardiovasc Pharmacol 20: 83-87.
20. Yang Z, Richard V, von Segesser L, Bauer E, Stulz P, Turina M & Lüscher TF (1990): Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm. Circulation 82: 188-195.